Skip to main content
Figure 3 | SpringerPlus

Figure 3

From: LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis

Figure 3

Immunohistochemistry of R58LAP-DP in fibrotic liver tissues in CCl 4 -treated mice using R58 antibody. Liver tissues from CCl4-treated and control (olive oil administrated) mice were stained by HE (a, d) vand Sirius Red ( b, e), and then immunostained with R58 antibody (c, f). Scale bar = 50 μm. The percentage of fibrotic regions and R58 positive areas were calculated from three fields each from five sections (5 mice) (total 15 fields) and described as average ± SE under the corresponding panels. A total of 16 mice were evaluated and representative results are shown.

Back to article page